Resources & Research

AHIP Members

AHIP Member Plan employees can log in to view additional content.

Don’t have a login? Register as a Member Plan employee.

State Law Chart • 09.15.2021

Step Therapy Law Chart

PDF Included

Members Only

Policy • 08.16.2021

Interchangeable Biosimilars Offer Great Promise for Affordable Life-Saving Drugs

PDF Included

Comment Letter • 08.11.2021

AHIP Letter Concerning National Coverage Determination Analysis for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease

PDF Included

State Law Chart • 09.10.2020

Formulary Management Law Chart

PDF Included

Members Only

State Law Chart • 07.02.2020

Drug Price Transparency Chart

PDF Included

Members Only

Research • 09.10.2019

The Rise Of Orphan Drugs

PDF Included

Comment Letter • 04.09.2019

AHIP Supports Key Provisions of “Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act”

PDF Included

Policy • 03.29.2019

Rebate Rule Would Increase Drug Prices, Premiums, and Costs to Taxpayers

PDF Included

Members Only

State Law Chart • 02.20.2019

Biosimilar Dispensing: Summary of State Requirements

PDF Included

Members Only

Comment Letter • 01.28.2019

AHIP Letter to Administrator Seema Verma on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses

PDF Included

Comment Letter • 12.17.2018

AHIP Comments on Medicare and Medicaid Programs: Regulation to Require Drug Pricing Transparency

PDF Included

Comment Letter • 08.21.2018

Letter to Senators Durbin and Grassley on Direct-to-Consumer Advertising

PDF Included

Our Health Equity Journey

Executive Leadership Program (ELP)

2025 Medicare, Medicaid, Duals & Commercial Markets Forum

Resources

AHIP Members login info box

Step Therapy Law Chart

Interchangeable Biosimilars Offer Great Promise for Affordable Life-Saving Drugs

AHIP Letter Concerning National Coverage Determination Analysis for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease

Formulary Management Law Chart

Drug Price Transparency Chart

The Rise Of Orphan Drugs

AHIP Supports Key Provisions of “Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act”

Rebate Rule Would Increase Drug Prices, Premiums, and Costs to Taxpayers

Biosimilar Dispensing: Summary of State Requirements

AHIP Letter to Administrator Seema Verma on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses

AHIP Comments on Medicare and Medicaid Programs: Regulation to Require Drug Pricing Transparency

Letter to Senators Durbin and Grassley on Direct-to-Consumer Advertising